Effect of high glucose on secreted proteome in cultured retinal pigmented epithelium cells: Its possible relevance to clinical diabetic retinopathy

Journal of Proteomics

Volumn 77, Issue , 2012, Pages 111-128

  Chen, You Hsuan ^a   Chou, Hsiu Chuan ^a   Lin, Szu Ting ^a   Chen, Yi Wen ^a   Lo, Yi Wen ^a   Chan, Hong Lin ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

2D DIGE; MALDI TOF MS; Proteomics; Retinal pigmented epithelium cells; Secretomics

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; CATHEPSIN D; GALECTIN 3; GLUCOSE; HAPTOGLOBIN; LYSOPHOSPHATIDIC ACID RECEPTOR; MANNITOL; MEMBRANE ASSOCIATED GUANYLATE CYCLASE KINASE; MOESIN; MULTIDRUG RESISTANCE PROTEIN 1; PROTEOME;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DIABETIC NEUROPATHY; GENE PRODUCT; HUMAN; HUMAN CELL; HYPERGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; PROTEIN TRANSPORT; PROTEOMICS;

BIOLOGICAL MARKERS; CELL LINE; DIABETIC RETINOPATHY; EPITHELIAL CELLS; EYE PROTEINS; GLUCOSE; HUMANS; MODELS, BIOLOGICAL; PROTEOME; RETINAL PIGMENT EPITHELIUM; SWEETENING AGENTS;

EID: 84870394170     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.07.014     Document Type: Article

References (44)

1. Dorchy H., Toussaint D. Early rupture of the blood-retina barrier in young diabetics. Initial functional disorder of retinopathy in type 1 diabetes in children and adolescents. Rev Med Brux 1984, 5:319-331.
2. van Reyk D.M., Gillies M.C., Davies M.J. The retina: oxidative stress and diabetes. Redox Rep 2003, 8:187-192.
3. Stitt A.W. AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci 2010, 51:4867-4874.
4. Gelisken F., Ziemssen F. Diabetic maculopathy. Diagnosis and treatment. Ophthalmologe 2010, 107:773-786.
5. Ehrlich R., Harris A., Ciulla T.A., Kheradiya N., Winston D.M., Wirostko B. Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process. Acta Ophthalmol 2010, 88:279-291.
6. Crawford T.N., Alfaro D.V., Kerrison J.B., Jablon E.P. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 2009, 5:8-13.
7. Girach A., Lund-Andersen H. Diabetic macular oedema: a clinical overview. Int J Clin Pract 2007, 61:88-97.
8. Huang H.L., Hsing H.W., Lai T.C., Chen Y.W., Lee T.R., Chan H.T., et al. Trypsin-induced proteome alteration during cell subculture in mammalian cells. J Biomed Sci 2010, 17:36.
9. Lai T.C., Chou H.C., Chen Y.W., Lee T.R., Chan H.T., Shen H.H., et al. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis. J Proteome Res 2010, 9:1302-1322.
10. Wu C.L., Chou H.C., Cheng C.S., Li J.M., Lin S.T., Chen Y.W., et al. Proteomic analysis of UVB-induced protein expression- and redox-dependent changes in skin fibroblasts using lysine- and cysteine-labeling two-dimensional difference gel electrophoresis. J Proteomics 2012, 75:1991-2014.
11. Chen Y.W., Chou H.C., Lyu P.C., Yin H.S., Huang F.L., Chang W.S., et al. Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers. Funct Integr Genomics 2011, 11:225-239.
12. Chou H.C., Chen Y.W., Lee T.R., Wu F.S., Chan H.T., Lyu P.C., et al. Proteomics study of oxidative stress and Src kinase inhibition in H9C2 cardiomyocytes: a cell model of heart ischemia reperfusion injury and treatment. Free Radic Biol Med 2010, 49:96-108.
13. Mannermaa E., Reinisalo M., Ranta V.P., Vellonen K.S., Kokki H., Saarikko A., et al. Filter-cultured ARPE-19 cells as outer blood-retinal barrier model. Eur J Pharm Sci 2010, 40:289-296.
14. Glotin A.L., Debacq-Chainiaux F., Brossas J.Y., Faussat A.M., Treton J., Zubielewicz A., et al. Prematurely senescent ARPE-19 cells display features of age-related macular degeneration. Free Radic Biol Med 2008, 44:1348-1361.
15. Garcia-Ramirez M., Villarroel M., Corraliza L., Hernandez C., Simo R. Measuring permeability in human retinal epithelial cells (ARPE-19): implications for the study of diabetic retinopathy. Methods Mol Biol 2011, 763:179-194.
16. Candiloros H., Muller S., Zeghari N., Donner M., Drouin P., Ziegler O. Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Influence of ketone bodies. Diabetes Care 1995, 18:549-551.
17. Saydah S.H., Miret M., Sung J., Varas C., Gause D., Brancati F.L. Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care 2001, 24:1397-1402.
18. Jouven X., Lemaitre R.N., Rea T.D., Sotoodehnia N., Empana J.P., Siscovick D.S. Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J 2005, 26:2142-2147.
19. Cai L., Li W., Wang G., Guo L., Jiang Y., Kang Y.J. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 2002, 51:1938-1948.
20. Chan H.L., Gharbi S., Gaffney P.R., Cramer R., Waterfield M.D., Timms J.F. Proteomic analysis of redox- and ErbB2-dependent changes in mammary luminal epithelial cells using cysteine- and lysine-labelling two-dimensional difference gel electrophoresis. Proteomics 2005, 5:2908-2926.
21. Chou H.C., Lu Y.C., Cheng C.S., Chen Y.W., Lyu P.C., Lin C.W., et al. Proteomic and redox-proteomic analysis of berberine-induced cytotoxicity in breast cancer cells. J Proteomics 2012, 75:3158-3176.
22. Izuta H., Matsunaga N., Shimazawa M., Sugiyama T., Ikeda T., Hara H. Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body. Mol Vis 2010, 16:130-136.
23. Xue H., Lu B., Lai M. The cancer secretome: a reservoir of biomarkers. J Transl Med 2008, 6:52.
24. Yamaguchi N., Yamamura Y., Koyama K., Ohtsuji E., Imanishi J., Ashihara T. Characterization of new human pancreatic cancer cell lines which propagate in a protein-free chemically defined medium. Cancer Res 1990, 50:7008-7014.
25. Inoue Y., Kawamoto S., Shoji M., Hashizume S., Teruya K., Katakura Y., et al. Properties of ras-amplified recombinant BHK-21 cells in protein-free culture. Cytotechnology 2000, 33:21-26.
26. Jacobs J.M., Mottaz H.M., Yu L.R., Anderson D.J., Moore R.J., Chen W.N., et al. Multidimensional proteome analysis of human mammary epithelial cells. J Proteome Res 2004, 3:68-75.
27. Koike M., Shibata M., Ohsawa Y., Nakanishi H., Koga T., Kametaka S., et al. Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice. Mol Cell Neurosci 2003, 22:146-161.
28. Bollineni J.S., Alluru I., Reddi A.S. Heparan sulfate proteoglycan synthesis and its expression are decreased in the retina of diabetic rats. Curr Eye Res 1997, 16:127-130.
29. Ringvall M., Kjellen L. Mice deficient in heparan sulfate N-deacetylase/N-sulfotransferase 1. Prog Mol Biol Transl Sci 2010, 93:35-58.
30. Grobe K., Ledin J., Ringvall M., Holmborn K., Forsberg E., Esko J.D., et al. Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes. Biochim Biophys Acta 2002, 1573:209-215.
31. Ringvall M., Ledin J., Holmborn K., van Kuppevelt T., Ellin F., Eriksson I., et al. Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J Biol Chem 2000, 275:25926-25930.
32. Khalfaoui T., Lizard G., Beltaief O., Colin D., Ben Hamida J., Errais K., et al. Immunohistochemical analysis of cellular adhesion molecules (ICAM-1, VCAM-1) and VEGF in fibrovascular membranes of patients with proliferative diabetic retinopathy: preliminary study. Pathol Biol (Paris) 2009, 57:513-517.
33. Khalfaoui T., Lizard G., Ouertani-Meddeb A. Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes. J Mol Histol 2008, 39:243-249.
34. Kamiuchi K., Hasegawa G., Obayashi H., Kitamura A., Ishii M., Yano M., et al. Intercellular adhesion molecule-1 (ICAM-1) polymorphism is associated with diabetic retinopathy in Type 2 diabetes mellitus. Diabet Med 2002, 19:371-376.
35. Lumeng C., Phelps S., Crawford G.E., Walden P.D., Barald K., Chamberlain J.S. Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases. Nat Neurosci 1999, 2:611-617.
36. Meng W., Mushika Y., Ichii T., Takeichi M. Anchorage of microtubule minus ends to adherens junctions regulates epithelial cell-cell contacts. Cell 2008, 135:948-959.
37. Shelton L., Rada J.A. Inhibition of human scleral fibroblast cell attachment to collagen type I by TGFBIp. Invest Ophthalmol Vis Sci 2009, 50:3542-3552.
38. Ziyadeh F.N., Fumo P., Rodenberger C.H., Kuncio G.S., Neilson E.G. Role of protein kinase C and cyclic AMP/protein kinase A in high glucose-stimulated transcriptional activation of collagen alpha 1 (IV) in glomerular mesangial cells. J Diabetes Complications 1995, 9:255-261.
39. Miles A.J., Skubitz A.P., Furcht L.T., Fields G.B. Promotion of cell adhesion by single-stranded and triple-helical peptide models of basement membrane collagen alpha 1(IV)531-543. Evidence for conformationally dependent and conformationally independent type IV collagen cell adhesion sites. J Biol Chem 1994, 269:30939-30945.
40. Tsukita S. ERM (ezrin/radixin/moesin) as crosslinkers between actin filaments and plasma membranes. Tanpakushitsu Kakusan Koso 1996, 41:1899-1905.
41. Ivanova S., Gregorc U., Vidergar N., Javier R., Bredt D.S., Vandenabeele P., et al. MAGUKs, scaffolding proteins at cell junctions, are substrates of different proteases during apoptosis. Cell Death Dis 2011, 2:e116.
42. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev 2005, 85:845-881.
43. Glenn J.V., Mahaffy H., Wu K., Smith G., Nagai R., Simpson D.A., et al. Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction. Invest Ophthalmol Vis Sci 2009, 50:441-451.
44. Chan H.L., Gharbi S., Gaffney P.R., Cramer R., Waterfield M.D., Timms J.F. Proteomic analysis of redox- and ErbB2-dependent changes in mammary luminal epithelial cells using cysteine- and lysine-labelling two-dimensional difference gel electrophoresis. Proteomics 2005, 5:2908-2926.